{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:38:09Z","timestamp":1792269489242,"version":"4.4.0"},"reference-count":25,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reports"],"abstract":"<jats:p>Background and Clinical Significance: Interstitial lung disease (ILD) is an uncommon but potentially serious complication of imatinib. Its histopathological characterization has so far relied on surgical biopsy or transbronchial forceps sampling, and no case characterized by transbronchial lung cryobiopsy (TBLC) has been reported. The single previous description of a non-specific interstitial pneumonia (NSIP) pattern with imatinib came from a surgical specimen and was cellular in type, with complete radiological resolution after withdrawal. Case Presentation: A 69-year-old never-smoker began imatinib 400 mg daily for Philadelphia chromosome-positive chronic myeloid leukemia; chest computed tomography performed immediately beforehand was normal. Approximately three months later, she developed dyspnea, dry cough and a cutaneous rash, progressing to acute respiratory failure with forced vital capacity 49% and diffusing capacity 30% of predicted. Avian exposure had ceased one month before symptom onset, and she had never received amiodarone. Although serum precipitins were unavailable, hypersensitivity pneumonitis was considered less likely given the temporal relationship but could not be definitively excluded. TBLC yielded specimens showing fibrotic thickening of the alveolar septa by hyaline collagen deposition with a focal lymphomonocytic infiltrate, corresponding to a fibrotic NSIP pattern. After drug withdrawal and administration of corticosteroids, forced vital capacity rose to 82% of predicted. Multidisciplinary discussion concluded that this was drug-induced ILD, graded probable on the Naranjo scale. Imatinib was subsequently replaced by bosutinib for insufficient molecular response, without pulmonary recurrence. Conclusions: Imatinib-associated ILD may present with an organizing-pneumonia-like radiological pattern followed by a fibrosing pattern, with cryobiopsy performed later demonstrating fibrotic NSIP. Because no tissue was obtained during the acute phase, this sequence remains a hypothesis rather than a demonstrated evolution. Cryobiopsy can be performed safely when surgical biopsy is not appropriate.<\/jats:p>","DOI":"10.3390\/reports9030303","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:13:03Z","timestamp":1789031583000},"page":"303","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Imatinib-Associated Interstitial Lung Disease with a Fibrotic NSIP Pattern on Transbronchial Lung Cryobiopsy: A Case Report and Review of the Literature"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3307-217X","authenticated-orcid":false,"given":"Pier-Valerio","family":"Mari","sequence":"first","affiliation":[{"name":"Internal Medicine, San Carlo di Nancy Hospital, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2538-1278","authenticated-orcid":false,"given":"Lorenzo","family":"Carriera","sequence":"additional","affiliation":[{"name":"Department of Pulmonology and Sub-Intensive Respiratory Unit, Santa Maria della Misericordia Hospital, 06156 Perugia, Italy"},{"name":"Faculty of Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2462-1613","authenticated-orcid":false,"given":"Filippo","family":"Lococo","sequence":"additional","affiliation":[{"name":"Department of General Thoracic Surgery, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Margaritora","sequence":"additional","affiliation":[{"name":"Department of General Thoracic Surgery, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2838-423X","authenticated-orcid":false,"given":"Simone","family":"Ielo","sequence":"additional","affiliation":[{"name":"UOC Pneumologia e UTIP, Ospedale San Donato, USL Toscana SudEst, 52100 Arezzo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Ojetti","sequence":"additional","affiliation":[{"name":"Internal Medicine, San Carlo di Nancy Hospital, 00165 Rome, Italy"},{"name":"UniCamillus International Medical University of Rome, 00131 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Onelli","sequence":"additional","affiliation":[{"name":"Interventional Pulmonology Unit, Department of Pulmonology, San Camillo de Lellis Hospital, ASL Rieti, 02100 Rieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7709-121X","authenticated-orcid":false,"given":"Fabrizio","family":"Liberati","sequence":"additional","affiliation":[{"name":"Unit of Pathological Anatomy, San Camillo de Lellis Hospital, ASL Rieti, 02100 Rieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Pietrangeli","sequence":"additional","affiliation":[{"name":"Interventional Pulmonology Unit, Department of Pulmonology, San Camillo de Lellis Hospital, ASL Rieti, 02100 Rieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/resp.70164","article-title":"Parsing the Patterns: Not All Drug-Induced Interstitial Lung Diseases Are Alike. Understanding Drug-Induced Interstitial Lung Disease in the Era of Targeted Cancer Therapy","volume":"31","author":"Boyle","year":"2026","journal-title":"Respirology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/bcp.70483","article-title":"Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases-An update","volume":"92","author":"Freppel","year":"2026","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000079633","article-title":"Interstitial lung disease induced by drugs and radiation","volume":"71","author":"Camus","year":"2004","journal-title":"Respiration"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2000279","DOI":"10.1183\/13993003.00279-2020","article-title":"Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors","volume":"56","author":"Weatherald","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s40264-016-0450-9","article-title":"Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas","volume":"39","author":"Shah","year":"2016","journal-title":"Drug Saf."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.leu.2404207","article-title":"Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate","volume":"20","author":"Ohnishi","year":"2006","journal-title":"Leukemia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-2141.2004.04833.x","article-title":"Interstitial pneumonitis during imatinib therapy","volume":"125","author":"Isshiki","year":"2004","journal-title":"Br. J. Haematol."},{"key":"ref_8","first-page":"437","article-title":"Toxicidad pulmonar inducida por imatinib [Imatinib-induced pulmonary toxicity]","volume":"145","year":"2009","journal-title":"Gac. Med. Mex."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3904\/kjim.2015.30.4.550","article-title":"Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection","volume":"30","author":"Lee","year":"2015","journal-title":"Korean J. Intern Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/bjh.15022","article-title":"Imatinib-related interstitial lung disease","volume":"180","author":"Guzelkucuk","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e14402","DOI":"10.1097\/MD.0000000000014402","article-title":"Imatinib-induced irreversible interstitial lung disease: A case report","volume":"98","author":"Zhang","year":"2019","journal-title":"Medicine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/resp.13822","article-title":"Lung cryobiopsy and interstitial lung disease: What is its role in the era of multidisciplinary meetings and antifibrotics?","volume":"25","author":"Troy","year":"2020","journal-title":"Respirology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1159\/000547111","article-title":"Bispecific T-Cell Engagers-Induced Interstitial Lung Disease: Two Case Reports Confirmed by Transbronchial Lung Cryobiopsy","volume":"104","author":"Morviducci","year":"2025","journal-title":"Respiration"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11782234241301314","DOI":"10.1177\/11782234241301314","article-title":"The Histopathology of Abemaciclib-Induced Interstitial Lung Disease: A First Case Report with Transbronchial Lung Cryobiopsy","volume":"18","author":"Kaburaki","year":"2024","journal-title":"Breast Cancer Basic Clin. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2424338","DOI":"10.1080\/09546634.2024.2424338","article-title":"Ixekizumab-induced interstitial lung disease: A case report confirmed by transbronchial lung cryobiopsy","volume":"35","author":"Kaburaki","year":"2024","journal-title":"J. Dermatol. Treat."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Muto, Y., Kuse, N., Inomata, M., Awano, N., Tone, M., Takada, K., Fujimoto, K., Bae, Y., Kumasaka, T., and Izumo, T. (2021). Drug-induced hypersensitivity syndrome caused by minodronic acid hydrate. BMC Pulm. Med., 21.","DOI":"10.1186\/s12890-021-01709-x"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6794343","DOI":"10.1155\/2017\/6794343","article-title":"Role of Transbronchial Lung Cryobiopsies in Diffuse Parenchymal Lung Diseases: Interest of a Sequential Approach","volume":"2017","author":"Bondue","year":"2017","journal-title":"Pulm. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1634\/theoncologist.2012-0248","article-title":"High-resolution computed tomography findings for patients with drug-induced pulmonary toxicity, with special reference to hypersensitivity pneumonitis-like patterns in gemcitabine-induced cases","volume":"18","author":"Tamura","year":"2013","journal-title":"Oncologist"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s00117-014-2737-0","article-title":"Medikamenteninduzierte interstitielle Lungenerkrankungen","volume":"54","author":"Poschenrieder","year":"2014","journal-title":"Radiologe"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e28701","DOI":"10.1097\/MD.0000000000028701","article-title":"A case report of nilotinib-induced irreversible interstitial lung disease","volume":"101","author":"Cho","year":"2022","journal-title":"Medicine"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Fenocchio, E., Depetris, I., Campanella, D., Garetto, L., Schianca, F.C., Galizia, D., Grignani, G., Aglietta, M., and Leone, F. (2016). Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: A case report. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2833-9"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ccr3.549","article-title":"Imatinib for bleomycin induced pulmonary toxicity: A case report and evidence-base review","volume":"4","author":"Banakh","year":"2016","journal-title":"Clin. Case Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bozzini, S., Bozza, E., Bagnera, C., Morbini, P., Lettieri, S., Della Zoppa, M., Melloni, G., Saracino, L., Belliato, M., and Meloni, F. (2024). Assessment of Imatinib Anti-Remodeling Activity on a Human Precision Cut Lung Slices Model. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158186"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13045-022-01309-0","article-title":"A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase","volume":"15","author":"Breccia","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/imj.14647","article-title":"Pulmonary function testing for the early detection of drug-induced lung disease: A systematic review in adults treated with drugs associated with pulmonary toxicity","volume":"50","author":"Bui","year":"2020","journal-title":"Intern Med. J."}],"container-title":["Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/3\/303\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:54:05Z","timestamp":1789034045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/3\/303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["reports9030303"],"URL":"https:\/\/doi.org\/10.3390\/reports9030303","relation":{},"ISSN":["2571-841X"],"issn-type":[{"value":"2571-841X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}